Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Rosuvastatin is safe and effective in children with familial hypercholesterolemia, although many will not achieve consensus targets for low density lipoprotein (LDL) cholesterol,…
NEW YORK (Reuters Health) – Adding a 2-week course of triple antibiotic therapy to existing medications helps induce and maintain remission of ulcerative colitis (UC), according to a…
NEW YORK (Reuters Health) – Adolescents with chronic pancreatitis can have long-term relief from pain after therapeutic endoscopic retrograde cholangiopancreatography (ERCP), researchers from China say. The goal of…
NEW YORK (Reuters Health) – Appropriate use of intravenous narcotics is safe and perhaps even beneficial in patients with acute coronary syndromes, according to Israeli researchers. In general,…
NEW YORK (Reuters Health) – A new practice parameter from the American Academy of Neurology calls for doctors to identify and treat nonmotor symptoms in patients with Parkinson’s…
NEW YORK (Reuters Health) – Drug-eluting stents in saphenous vein grafts have a lower risk of revascularization than bare-metal stents, according to a meta-analysis of data on nearly…
NEW YORK (Reuters Health) – As first-line treatment for progressive chronic lymphocytic leukemia (CLL), cladribine and fludarabine are equally effective and safe in combination with cyclophosphamide, according to…
NEW YORK (Reuters Health) – Use of insulin glargine or detemir rather than NPH insulin does not reduce the risk of ketoacidosis in children and adolescents with type…
NEW YORK (Reuters Health) – There’s no good evidence that maintenance therapy improves the outcome of small-cell lung cancer (SCLC), according to a meta-analysis published February 25th in…
NEW YORK (Reuters Health) – Some patients with ocular hypertension are at low risk of progressing to open-angle glaucoma and don’t need treatment, research shows. But for patients…
